Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
about
Noonan syndromeParaspinal neurofibromas and hypertrophic neuropathy in Noonan syndrome with multiple lentigines.Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in CancerRisk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).Noonan syndrome.Association of polymorphism of PTPN 11 encoding SHP-2 with gastric atrophy but not gastric cancer in Helicobacter pylori seropositive Chinese population.K-RasV14I recapitulates Noonan syndrome in mice.Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromesNew Genetic Insights into Congenital Heart Disease.Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.Syndrome-Associated Tumors by Organ System.Genetic predispositions to childhood leukemia.Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.The role of the RAS pathway in iAMP21-ALL.Noonan syndrome - a new survey.Malignancy in Noonan syndrome and related disorders.Occurrence of Cranial Neoplasms in Pediatric Patients with Noonan Syndrome Receiving Growth Hormone: Is Screening with Brain MRI prior to Initiation of Growth Hormone Indicated?Molecular Diversity and Associated Phenotypic Spectrum of Germline CBL Mutations.Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome.Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.K-Ras(V14I) -induced Noonan syndrome predisposes to tumour development in mice.Update on Genetic Conditions Affecting the Skin and the Kidneys.Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation.Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosisMultiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship?
P2860
Q27001641-AB083609-D32D-4ED0-B7B8-610FDAD06D0EQ30278754-1E2475FE-3E63-4C21-83ED-89A53EDB284AQ31032861-1007F853-8CCC-4EC7-BB37-71DB5245A7FFQ33570283-C043488B-4598-41E6-BB90-CF119BFD9DA6Q33701036-4BAF0E83-B527-4191-A3B1-E62DE1ACDE93Q33904939-BF4DCBA6-AFFD-435E-AFC6-A0FCE2D385EEQ34334450-60432735-CF29-4C16-84BF-15BF3682A9BAQ34581270-3EBCA55B-A981-4022-8243-5C4FE56F6623Q35475470-FF2C591F-6A48-49E7-AA89-2E986BFFF2F3Q36106143-5D24B70E-B793-4BAC-975D-F782F4A28C1FQ36127065-332D8A92-B992-4CA6-A245-B05196D926CFQ37032662-592369E2-E461-4432-8E43-B707E849946FQ37073895-3BD5F764-B37E-4D17-BED3-83A704A6C439Q37212868-9648FA06-FBCD-4A85-BB54-912853B051CBQ37245131-0FCDE3D8-62CE-4637-B036-79778A4D49C9Q37549407-8543501F-7BE4-48C2-897B-64F5F355D1E9Q38356240-8C935E34-AB9B-43AC-B8D9-D1D63B157D64Q48178392-EF0E2BC9-514E-4674-92C7-D1D627D1653BQ50587974-33F4F387-1E78-4F43-A290-E76E272AC611Q50607668-810D2D51-6CDB-467E-BD7F-B1701A6782E1Q52101515-C89E2F72-5E9C-4BE0-B264-A166B8C8C3D2Q52149150-5AC69FB4-2B83-41F9-94FD-40ECBFC24DC6Q52793910-B7690643-8B21-4C7D-95B4-D03EABA1B7BEQ53072085-F2E713E4-97DD-4DD4-8008-500A80F564FAQ53101926-1DBA10CA-5D18-4F5D-8C7F-EA6E0D66F893Q55140325-B61E7E57-F73B-4CA3-8613-9C31DFB203F1Q55461559-C490CC43-F160-480D-9C47-5426A44622FBQ56770882-504A0D4C-CE07-4514-B4BC-1365A9A0EC7DQ57234950-776E48FE-159D-4DD9-9714-858805FD4BF6
P2860
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
@ast
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
@en
type
label
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
@ast
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
@en
prefLabel
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
@ast
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
@en
P2093
P2860
P50
P356
P1476
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
@en
P2093
Ad Geurts van Kessel
Helger G Yntema
Ineke van der Burgt
Marjolijn C J Jongmans
Marjolijn J L Ligtenberg
Nicoline Hoogerbrugge
Peter M Hoogerbrugge
Roland P Kuiper
Willy M Nillesen
P2860
P2888
P304
P356
10.1038/EJHG.2011.37
P407
P577
2011-03-16T00:00:00Z